Lv42
590 积分 2023-06-16 加入
Long‐term safety and efficacy of the sodium–glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week open‐label, multicenter, post‐marketing clinical study
12天前
已完结
Placebo or vehicle effects on dry eye signs and symptoms in randomized controlled trials: A systematic review and meta-analysis
12天前
已完结
Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)
13天前
已完结
Outcome Measures and Clinical Results of Trials for United States Regulatory Approval of Dry Eye Therapeutics
14天前
已完结
Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells
1个月前
已完结
Safety of Moxifloxacin as Shown in Animal and In Vitro Studies
1个月前
已完结
Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells
1个月前
已完结
Intravitreal Toxicity of Levofloxacin and Gatifloxacin
1个月前
已关闭
Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy
1个月前
已完结
TFOS DEWS II Diagnostic Methodology report
1个月前
已完结
皖公网安备34019202002308
